Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Oral Sessions

Monday July 8

F-I4 Developing Youth Friendly Programs
4 Oral Abstract Session
Venue: Hall 5:7
Date: Monday, July o8, 2002
Time: 16:oo- 17:3o0
Chairs: Ron Valdiserri, United States
Jose Antonio Taboada Rodriguez, Spain

17:15 MoOrG1128 Developing political support among
legislators and community leaders for
reform of drug sentencing laws that
contribute to HIV/AIDS in New York
State's inmate population
D P Small (United States)
Opportunities and Challenges in Vaccine Research
Bs03 and Development

16:oo MoOrF1117
16:15 MoOrF1118

Coordination of health and education
service in STD/AIDS prevention
VS Lopes, D Doneda (Brazil)
Youth friendly voluntary counseling and
testing in Nairobi, Kenya
A Laibuta C Rachier, E Marum,
E Gikundi, I Ouko, G Njoka, E Shitekha,
D Balmer (Kenya)
Coming out of the shadows: sexual
culture of young bakla in the Philippines
I Castro (Philippines)

Venue:
Date:
Time:
Chairs:

Bridging Session
Hall 1:2
Monday, July 08, 2002
16:oo - 17:3o
Jose Esparza, WHO
Craig McClure, Canada

Monday

16:30 MoOrF1119

16:45 MoOrF1120 Evaluation of a gender- and culturallyappropriate sexual health promotion
program for high-risk African American
female adolescents
R J DiClemente GM Wingood
(United States)
17:00 MoOrF1121 Challenges in creating adolescentfriendly reproductive health environment
in Bangladesh
I Bhuiya U Rob, M E Khan (Bangladesh)
17:15 MoOrF1122 The role of Non-Governmental
Organizations (NGOs) networking in
HIV/AIDS prevention programs
implementation in the conditions of state
health reform (Bulgarian and Balkan
region outcomes)
R Stamenkova D Georgieva (Bulgaria)
G03 Harm Reduction and Policy Implications
0. Oral Abstract Session
Venue: Hall 2:2
Date: Monday, July o8, 2002
Time: 16:oo- 17:3o
Chairs: Phillipa Lawson, United States
Joan Colom, Spain

16:oo MoOrl33
16:20 MoOrl34
16:40 MoOrl35
17:00 MoOr136

Challenges in basic science
Andrew McMichael TBC
(United Kingdom)
Practical policies and challenges in
vaccine research and development
Punnee Pitisutsuttithum (Thailand)
Community involvement
Jorge Belogui (Brazil)
Impact of a partially effective vaccine
Roy Anderson (United States)

SYA021 New Drugs, New Targets
Symposium Session
Venue: Hall Verdi
Date: Monday, July o8, 2002
Time: 16:oo- 17:3o
Chairs: John Sullivan, United States
Jose Este, Spain
16:oo MoOrAl37 Integrase Inhibitors
Daria Hazuda (United States)
16:15 MoOrAl38 Co-receptor inhibitors
Bahige Baroudy (United States)
16:30 MoOrAl39 Fusion Inhibitors
Michael Greenberg (United States)
16:45 MoOrA14o 2nd Generation
William Olson (United States)
17:00oo MoOrA141 New Agents in Early Clinical
Development
Robert Murphy (United States)

16:oo MoOrG1123

Establishing safe injection facilities in
Canada: legal and ethical issues
I Malkin', R Elliott2, J Gold 2
('Australia; 2Canada)

16:15 MoOrG1124 Rapid assessment of drug and harm
reduction policies in Eastern Europe and
the former Soviet Union
Z Lazzarini, S Burris, P Case,
D Abrahamson, I Welsh (United States)
16:30 MoOrG1125 Addressing the issue of HIV spread
among drug users in sub-Saharan Africa:
networking to reduce harm
A 0 Akinhanmi, R A Lawal (Nigeria)
16:45 MoOrG1126 Repressive drug policy in Argentina as
key factor casting drug users out of HIV
prevention
GHU Hurtado S S I Inchaurraga,
M VA Vdzquez, Acufia Martin (Argentina)
17:00oo MoOrG1127 Impeding and supporting factors for
harm reduction program in Indonesia
I Irwanto (Indonesia)

24 Final Program